Skip to main navigation menu Skip to main content Skip to site footer
##common.pageHeaderLogo.altText##

Original article

Vol. 153 No. 11 (2023)

National survey in Switzerland calls for improved diagnosis and treatment in children with scabies

  • Michael Buettcher
  • Anita K. Stebler
  • Martin Theiler
  • Kevin Kobylinski
  • Marc Pfister
DOI
https://doi.org/10.57187/smw.2023.40129
Cite this as:
Swiss Med Wkly. 2023;153:40129
Published
28.11.2023

Summary

AIM OF THE STUDY: The global prevalence of scabies is estimated to be up to 200 million cases annually, with young children particularly affected. In Europe, most cases are thought to originate in migrant populations. Scabies management is challenging in children. To identify knowledge gaps and research needs, we aimed to descriptively evaluate the management of children with scabies by different Swiss healthcare providers.

METHODS: An invitation for an anonymous online survey (36 questions) was sent to members of Swiss societies of dermatologists, general practitioners, paediatricians, paediatric dermatologists, paediatric infectious diseases specialists, and tropical medicine specialists, inviting clinicians to participate from 25th May to 8th August 2020. One reminder invitation was sent. Hospital pharmacies and the distributor of permethrin were contacted to report consumption trends of scabicides in 2018 and 2019.

RESULTS: The survey was completed by 248 clinicians: 146 (59%) paediatricians, 47 (19%) dermatologists, 28 (11%) general practitioners, 6 (2%) paediatric dermatologists, 13 (5%) paediatric infectious diseases specialists, and 8 (3%) tropical medicine specialists. Most consulted up to 10 scabies cases within a 16-month period, with similar numbers in migrant and Swiss children. Dermoscopy was used by 24% of non-dermatologists. Non-dermatologists did not consider co-treatment of close contacts in up to 59% of cases. While permethrin was the first-line treatment, treatment failures were frequently reported in children aged <5 years. Up to 67% of paediatric dermatologists regularly used oral ivermectin off-label in children weighing <15 kg. None of the paediatric dermatologists, 15% of the dermatologists, and 9% of the non-dermatologists used only one treatment cycle.Scabicide consumption increased. Treatment studies on ivermectin use in children weighing <15 kg had the highest research priority.

CONCLUSION: In Switzerland, scabies is a frequent dermatosis in migrant and Swiss children. While accessible, optimal diagnostics are underutilised, and treatment is suboptimal. Permethrin resistance appears to be an increasing problem. Dermatologists regularly use ivermectin off-label in children weighing <15 kg. Treatment studies on ivermectin use in children weighing <15 kg, user-friendly diagnostic tools, new treatment protocols, and child-friendly dosage forms are needed to improve the diagnosis and treatment of children with scabies.

References

  1. Chandler DJ, Fuller LC. A Review of Scabies: An Infestation More than Skin Deep. Dermatology. 2019;235(2):79–90. 10.1159/000495290 DOI: https://doi.org/10.1159/000495290
  2. Chosidow O. Clinical practices. Scabies. N Engl J Med. 2006 Apr;354(16):1718–27. 10.1056/NEJMcp052784 DOI: https://doi.org/10.1056/NEJMcp052784
  3. Disease GB, Injury I, Prevalence C; GBD 2017 Disease and Injury Incidence and Prevalence Collaborators. Global, regional, and national incidence, prevalence, and years lived with disability for 354 diseases and injuries for 195 countries and territories, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017. Lancet. 2018 Nov;392(10159):1789–858. 10.1016/S0140-6736(18)32279-7
  4. Karimkhani C, Colombara DV, Drucker AM, Norton SA, Hay R, Engelman D, et al. The global burden of scabies: a cross-sectional analysis from the Global Burden of Disease Study 2015. Lancet Infect Dis. 2017 Dec;17(12):1247–54. 10.1016/S1473-3099(17)30483-8 DOI: https://doi.org/10.1016/S1473-3099(17)30483-8
  5. Sunderkötter C, Aebischer A, Neufeld M, Löser C, Kreuter A, Bialek R, et al. Increase of scabies in Germany and development of resistant mites? Evidence and consequences. J Dtsch Dermatol Ges. 2019 Jan;17(1):15–23. 10.1111/ddg.13706 DOI: https://doi.org/10.1111/ddg.13706
  6. Di Meco E, Di Napoli A, Amato LM, Fortino A, Costanzo G, Rossi A, et al.; INMP Team. Infectious and dermatological diseases among arriving migrants on the Italian coasts. Eur J Public Health. 2018 Oct;28(5):910–6. 10.1093/eurpub/cky126 DOI: https://doi.org/10.1093/eurpub/cky126
  7. Zhang W, Zhang Y, Luo L, Huang W, Shen X, Dong X, et al. Trends in prevalence and incidence of scabies from 1990 to 2017: findings from the global Burden of disease study 2017. Emerg Microbes Infect. 2020 Dec;9(1):813–6. 10.1080/22221751.2020.1754136 DOI: https://doi.org/10.1080/22221751.2020.1754136
  8. Boralevi F, Diallo A, Miquel J, Guerin-Moreau M, Bessis D, Chiavérini C, et al.; Groupe de Recherche Clinique en Dermatologie Pédiatrique. Clinical phenotype of scabies by age. Pediatrics. 2014 Apr;133(4):e910–6. 10.1542/peds.2013-2880 DOI: https://doi.org/10.1542/peds.2013-2880
  9. Brockman R, Leitenberger S. Review of Scabies Infestation and Selected Common Cutaneous Infections. Pediatr Rev. 2021 Jan;42(1):21–32. 10.1542/pir.2018-0305 DOI: https://doi.org/10.1542/pir.2018-0305
  10. Engelman D, Yoshizumi J, Hay RJ, Osti M, Micali G, Norton S, et al. The 2020 International Alliance for the Control of Scabies Consensus Criteria for the Diagnosis of Scabies. Br J Dermatol. 2020 Nov;183(5):808–20. 10.1111/bjd.18943 DOI: https://doi.org/10.1111/bjd.18943
  11. Salavastru CM, Chosidow O, Boffa MJ, Janier M, Tiplica GS. European guideline for the management of scabies. J Eur Acad Dermatol Venereol. 2017 Aug;31(8):1248–53. 10.1111/jdv.14351 DOI: https://doi.org/10.1111/jdv.14351
  12. Aussy A, Houivet E, Hébert V, Colas-Cailleux H, Laaengh N, Richard C, et al.; investigators from the Normandy Association of Medical Education in Dermatology. Risk factors for treatment failure in scabies: a cohort study. Br J Dermatol. 2019 Apr;180(4):888–93. 10.1111/bjd.17348 DOI: https://doi.org/10.1111/bjd.17348
  13. Chosidow A, Gendrel D. [Safety of oral ivermectin in children]. Arch Pediatr. 2016 Feb;23(2):204–9. 10.1016/j.arcped.2015.11.002 DOI: https://doi.org/10.1016/j.arcped.2015.11.002
  14. Rosumeck S, Nast A, Dressler C. Evaluation of Ivermectin vs Permethrin for Treating Scabies-Summary of a Cochrane Review. JAMA Dermatol. 2019 Jun;155(6):730–2. 10.1001/jamadermatol.2019.0279 DOI: https://doi.org/10.1001/jamadermatol.2019.0279
  15. Levy M, Martin L, Bursztejn AC, Chiaverini C, Miquel J, Mahé E, et al.; Groupe de Recherche de la Société Française de Dermatologie Pédiatrique. Ivermectin safety in infants and children under 15 kg treated for scabies: a multicentric observational study. Br J Dermatol. 2020 Apr;182(4):1003–6. 10.1111/bjd.18369 DOI: https://doi.org/10.1111/bjd.18369
  16. Berthe-Aucejo A, Prot-Labarthe S, Pull L, Lorrot M, Touratier S, Trout H, et al. [Treatment of scabies and Ascabiol(®) supply disruption: what about the pediatric population?]. Arch Pediatr. 2014 Jun;21(6):670–5. 10.1016/j.arcped.2014.03.001 DOI: https://doi.org/10.1016/j.arcped.2014.03.001
  17. Wenk C, Itin PH. Epidemiology of pediatric dermatology and allergology in the region of Aargau, Switzerland. Pediatr Dermatol. 2003;20(6):482–7. 10.1111/j.1525-1470.2003.20605.x DOI: https://doi.org/10.1111/j.1525-1470.2003.20605.x
  18. Genton PC, Wang J, Bodenmann P, Ambresin AE. Clinical profile and care pathways among unaccompanied minor asylum seekers in Vaud, Switzerland. Int J Adolesc Med Health. 2019 Sep;34(3):20190140. 10.1515/ijamh-2019-0140 DOI: https://doi.org/10.1515/ijamh-2019-0140
  19. Pohl C, Mack I, Schmitz T, Ritz N. The spectrum of care for pediatric refugees and asylum seekers at a tertiary health care facility in Switzerland in 2015. Eur J Pediatr. 2017 Dec;176(12):1681–7. 10.1007/s00431-017-3014-9 DOI: https://doi.org/10.1007/s00431-017-3014-9
  20. Engelman D, Fuller LC, Steer AC, panel IAftCoSD. Consensus criteria for the diagnosis of scabies: A Delphi study of international experts. 2018. e0006549. DOI: https://doi.org/10.1371/journal.pntd.0006549
  21. Lê MS, Richard MA, Baumstarck K, Hesse S, Gaudy-Marqueste C, Grob JJ, et al.; le groupe de recherche en dermatologie pédiatrique de la Société Française de Dermatologie. [Evaluation of practices in the management of scabies in children]. Ann Dermatol Venereol. 2017 May;144(5):341–8. DOI: https://doi.org/10.1016/j.annder.2016.12.008
  22. Schmidt-Guerre AR, Aranda-Hulin B, Maumy-Bertrand M, Aubin F. [Diagnosis and treatment of scabies by general practitioners: A survey of practices in France]. Ann Dermatol Venereol. 2018 Feb;145(2):89–94. 10.1016/j.annder.2017.09.591 DOI: https://doi.org/10.1016/j.annder.2017.09.591
  23. Thomas C, Rehmus W, Chang AY. Treatment practices in the management of scabies in infants younger than two months. Pediatr Dermatol. 2021 Mar;38(2):431–5. 10.1111/pde.14523 DOI: https://doi.org/10.1111/pde.14523
  24. Bassi A, Mazzatenta C, Piccolo V. Diagnosis and management of pediatric scabies: results from a survey on 317 Italian dermatologists. Travel Med Infect Dis. 2022;50:102461. 10.1016/j.tmaid.2022.102461 DOI: https://doi.org/10.1016/j.tmaid.2022.102461
  25. Amato E, Dansie LS, Grøneng GM, Blix HS, Bentele H, Veneti L, et al. Increase of scabies infestations, Norway, 2006 to 2018. Euro Surveill. 2019 Jun;24(23):24. 10.2807/1560-7917.ES.2019.24.23.190020 DOI: https://doi.org/10.2807/1560-7917.ES.2019.24.23.190020
  26. Aždajić MD, Bešlić I, Gašić A, Ferara N, Pedić L, Lugović-Mihić L. Increased Scabies Incidence at the Beginning of the 21st Century: What Do Reports from Europe and the World Show? Life (Basel). 2022 Oct;12(10):12. DOI: https://doi.org/10.3390/life12101598
  27. van Deursen B, Hooiveld M, Marks S, Snijdewind I, van den Kerkhof H, Wintermans B, et al. Increasing incidence of reported scabies infestations in the Netherlands, 2011-2021. PLoS One. 2022 Jun;17(6):e0268865. 10.1371/journal.pone.0268865 DOI: https://doi.org/10.1371/journal.pone.0268865
  28. Martinez-Garcia E, Grau-Perez M, Buendia-Eisman A, Garcia-Doval I. Prescriptions for scabies are rapidly increasing in Spain: an ecological study with national prescription data, 2008-2021. J Eur Acad Dermatol Venereol. 2022. DOI: https://doi.org/10.1111/jdv.18599
  29. Executive Committee of Guideline for the D. Treatment of S. Guideline for the diagnosis and treatment of scabies in Japan (third edition): Executive Committee of Guideline for the Diagnosis and Treatment of Scabies. J Dermatol. 2017;44; 991-1014. DOI: https://doi.org/10.1111/1346-8138.13896
  30. Banerji A; Canadian Paediatric Society, First Nations, Inuit and Métis Health Committee. Scabies. Paediatr Child Health. 2015 Oct;20(7):395–402. 10.1093/pch/20.7.395 DOI: https://doi.org/10.1093/pch/20.7.395
  31. Sunderkötter C, Mayser P, Fölster-Holst R, Maier WA, Kampen H, Hamm H. Scabies. J Dtsch Dermatol Ges. 2007 May;5(5):424–30. 10.1111/j.1610-0387.2007.06298.x DOI: https://doi.org/10.1111/j.1610-0387.2007.06298.x
  32. Lima FC, Cerqueira AM, Guimarães MB, Padilha CB, Craide FH, Bombardelli M. Crusted scabies due to indiscriminate use of glucocorticoid therapy in infant. An Bras Dermatol. 2017;92(3):383–5. 10.1590/abd1806-4841.20174433 DOI: https://doi.org/10.1590/abd1806-4841.20174433
  33. Sunderkötter C, Wohlrab J, Hamm H. Scabies: Epidemiology, Diagnosis, and Treatment. Dtsch Arztebl Int. 2021 Oct;118(41):695–704. DOI: https://doi.org/10.3238/arztebl.m2021.0296
  34. Anderson KL, Strowd LC. Epidemiology, Diagnosis, and Treatment of Scabies in a Dermatology Office. J Am Board Fam Med. 2017 Jan;30(1):78–84. 10.3122/jabfm.2017.01.160190 DOI: https://doi.org/10.3122/jabfm.2017.01.160190
  35. Johnston G, Sladden M. Scabies: diagnosis and treatment. BMJ. 2005 Sep;331(7517):619–22. 10.1136/bmj.331.7517.619 DOI: https://doi.org/10.1136/bmj.331.7517.619
  36. Golant AK, Levitt JO. Scabies: a review of diagnosis and management based on mite biology. Pediatr Rev. 2012 Jan;33(1):e1–12. 10.1542/pir.33.1.e1 DOI: https://doi.org/10.1542/pir.33.1.e1
  37. Ständer S, Ständer S. Itch in Scabies-What Do We Know? Front Med (Lausanne). 2021 Feb;8:628392. 10.3389/fmed.2021.628392 DOI: https://doi.org/10.3389/fmed.2021.628392
  38. Balestri R, Magnano M, Infusino SD, Rizzoli L, Girardelli CR, Rech G. Scabies is becoming less sensitive to permethrin therapy. J Eur Acad Dermatol Venereol. 2021 Dec;35(12):e889–91. 10.1111/jdv.17538 DOI: https://doi.org/10.1111/jdv.17538
  39. Mazzatenta C, Piccolo V, Argenziano G, Bassi A. Is Scabies becoming less sensitive to permethrin therapy? J Eur Acad Dermatol Venereol. 2021 Sep;35(9):e607–9. 10.1111/jdv.17339 DOI: https://doi.org/10.1111/jdv.17339
  40. Yürekli A. Is there a really resistance to scabies treatment with permethrin? In vitro killing activity of permethrin on Sarcoptes scabiei from patients with resistant scabies. Dermatol Ther. 2022 Mar;35(3):e15260. 10.1111/dth.15260 DOI: https://doi.org/10.1111/dth.15260
  41. Jittamala P, Monteiro W, Smit MR, Pedrique B, Specht S, Chaccour CJ, et al. A systematic review and an individual patient data meta-analysis of ivermectin use in children weighing less than fifteen kilograms: is it time to reconsider the current contraindication? PLoS Negl Trop Dis. 2021 Mar;15(3):e0009144. 10.1371/journal.pntd.0009144 DOI: https://doi.org/10.1371/journal.pntd.0009144
  42. Nicolas P, Maia MF, Bassat Q, Kobylinski KC, Monteiro W, Rabinovich NR, et al. Safety of oral ivermectin during pregnancy: a systematic review and meta-analysis. Lancet Glob Health. 2020 Jan;8(1):e92–100. 10.1016/S2214-109X(19)30453-X DOI: https://doi.org/10.1016/S2214-109X(19)30453-X
  43. King CL. Is ivermectin safe in pregnancy? Lancet Glob Health. 2020 Jan;8(1):e12–3. 10.1016/S2214-109X(19)30490-5 DOI: https://doi.org/10.1016/S2214-109X(19)30490-5
  44. Wilkins AL, Steer AC, Cranswick N, Gwee A. Question 1: is it safe to use ivermectin in children less than five years of age and weighing less than 15 kg? Arch Dis Child. 2018 May;103(5):514–9. 10.1136/archdischild-2017-314505 DOI: https://doi.org/10.1136/archdischild-2017-314505
  45. Engelman D, Cantey PT, Marks M, Solomon AW, Chang AY, Chosidow O, et al. The public health control of scabies: priorities for research and action. Lancet. 2019 Jul;394(10192):81–92. 10.1016/S0140-6736(19)31136-5 DOI: https://doi.org/10.1016/S0140-6736(19)31136-5

Most read articles by the same author(s)